Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Gheorghe‐Andrei Dan, Antoni Martínez‐Rubio, Stefan Agewall, Giuseppe Boriani, Martin Borggrefe, Fiorenzo Gaïta, Isabelle C. Van Gelder, Bülent Görenek, Juan Carlos Kaski, Keld Kjeldsen, Professor Gregory Lip, Béla Merkely, Ken Okumura, Jonathan P. Piccini, Tatjana Potpara, Birgitte Klindt Poulsen, Magdi Saba, Irina Savelieva, Juan Tamargo, Christian Wolpert, Christian Sticherling, Joachim R. Ehrlich, Richard J. Schilling, Nikola Pavlović, Tom De Potter, Andrzej Lubiński, Jesper Hastrup Svendsen, K N Ching, John L. Sapp, Carol Chen‐Scarabelli, Felipe A. Martínez (2018). Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). , 20(5), DOI: https://doi.org/10.1093/europace/eux373.
